What does it take to make a natural killer?

[1]  J. D. Di Santo,et al.  IL-15 is an essential mediator of peripheral NK-cell homeostasis. , 2003, Blood.

[2]  M. Caligiuri,et al.  CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity. , 2003, Blood.

[3]  Ellen V Rothenberg,et al.  Regulatory coding of lymphoid lineage choice by hematopoietic transcription factors. , 2003, Current opinion in immunology.

[4]  M. Caligiuri,et al.  In vivo evidence for a dependence on interleukin 15 for survival of natural killer cells. , 2002, Blood.

[5]  Kazuyoshi Takeda,et al.  New aspects of natural-killer-cell surveillance and therapy of cancer , 2002, Nature Reviews Cancer.

[6]  T. Waldmann,et al.  IL-15Rα Recycles and Presents IL-15 In trans to Neighboring Cells , 2002 .

[7]  I. Weissman,et al.  Enforced Expression of Bcl-2 Restores the Number of NK Cells, But Does Not Rescue the Impaired Development of NKT Cells or Intraepithelial Lymphocytes, in IL-2/IL-15 Receptor β-Chain-Deficient Mice1 , 2002, The Journal of Immunology.

[8]  P. Pandolfi,et al.  The ETS protein MEF plays a critical role in perforin gene expression and the development of natural killer and NK-T cells. , 2002, Immunity.

[9]  S. Jacobsen,et al.  Key role of flt3 ligand in regulation of the common lymphoid progenitor but not in maintenance of the hematopoietic stem cell pool. , 2002, Immunity.

[10]  D. Gilliland,et al.  Molecular genetics of human leukemias: new insights into therapy. , 2002, Seminars in hematology.

[11]  A. Ashkar,et al.  Decidual natural killer cells: key regulators of placental development (a review). , 2002, Journal of reproductive immunology.

[12]  Todd A Fehniger,et al.  Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect. , 2002, Blood.

[13]  A. Pizzey,et al.  An activating mutation in the transmembrane domain of the granulocyte colony-stimulating factor receptor in patients with acute myeloid leukemia , 2002, Oncogene.

[14]  M. Gassmann,et al.  Viable c-Kit(W/W) mutants reveal pivotal role for c-kit in the maintenance of lymphopoiesis. , 2002, Immunity.

[15]  P. Leibson,et al.  Natural killer cell activation in mice and men: different triggers for similar weapons? , 2002, Nature Immunology.

[16]  A. Moffett-King.  Natural killer cells and pregnancy , 2002, Nature Reviews Immunology.

[17]  A. Cumano,et al.  The hare and the tortoise: an embryonic haematopoietic race , 2002, Nature Reviews Immunology.

[18]  H. Igarashi,et al.  Transcription from the RAG1 locus marks the earliest lymphocyte progenitors in bone marrow. , 2002, Immunity.

[19]  Jun Zhou,et al.  A Role for NF-κB Activation in Perforin Expression of NK Cells Upon IL-2 Receptor Signaling1 , 2002, The Journal of Immunology.

[20]  J. Orange,et al.  Deficient natural killer cell cytotoxicity in patients with IKK-γ/NEMO mutations , 2002 .

[21]  W. Yokoyama,et al.  In vivo developmental stages in murine natural killer cell maturation , 2002, Nature Immunology.

[22]  C. Jasmin,et al.  Fibroblasts from Human Spleen Regulate NK Cell Differentiation from Blood CD34+ Progenitors Via Cell Surface IL-151 , 2002, The Journal of Immunology.

[23]  M. Collins,et al.  IL-21 limits NK cell responses and promotes antigen-specific T cell activation: a mediator of the transition from innate to adaptive immunity. , 2002, Immunity.

[24]  R. Biassoni,et al.  Early expression of triggering receptors and regulatory role of 2B4 in human natural killer cell precursors undergoing in vitro differentiation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[25]  Katia Perruccio,et al.  Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic Transplants , 2002, Science.

[26]  L. Teyton,et al.  A Thymic Precursor to the NK T Cell Lineage , 2002, Science.

[27]  S. Peters,et al.  Distinction between IL‐13+ and IFN‐γ+ natural killer cells and regulation of their pool size by IL‐4 , 2002, European journal of immunology.

[28]  Hyun-Jun Lee,et al.  PU.1 regulates expression of the interleukin-7 receptor in lymphoid progenitors. , 2002, Immunity.

[29]  C. Schaniel,et al.  Multiple hematopoietic cell lineages develop in vivo from transplanted Pax5-deficient pre-B I-cell clones. , 2002, Blood.

[30]  Christopher B Wilson,et al.  Enforced expression of the Ikaros isoform IK5 decreases the numbers of extrathymic intraepithelial lymphocytes and natural killer 1.1+ T cells. , 2002, Blood.

[31]  R. Zhao,et al.  The BCR/ABL Transgene Causes Abnormal NK Cell Differentiation and Can Be Found in Circulating NK Cells of Advanced Phase Chronic Myelogenous Leukemia Patients1 , 2002, The Journal of Immunology.

[32]  C. Murre,et al.  The function of E- and id proteins in lymphocyte development , 2001, Nature Reviews Immunology.

[33]  M. Caligiuri,et al.  The biology of human natural killer-cell subsets. , 2001, Trends in immunology.

[34]  P. Burkett,et al.  T Cell–Independent Interleukin 15rα Signals Are Required for Bystander Proliferation , 2001, The Journal of experimental medicine.

[35]  W. Yokoyama,et al.  Specific and nonspecific NK cell activation during virus infection , 2001, Nature Immunology.

[36]  B. Perussia,et al.  Final steps of natural killer cell maturation: a model for type 1–type 2 differentiation? , 2001, Nature Immunology.

[37]  C. Kinnon,et al.  Defective expression of the interleukin-2/interleukin-15 receptor beta subunit leads to a natural killer cell-deficient form of severe combined immunodeficiency. , 2001, Blood.

[38]  J. Miller,et al.  Human natural killer cells with polyclonal lectin and immunoglobulinlike receptors develop from single hematopoietic stem cells with preferential expression of NKG2A and KIR2DL2/L3/S2. , 2001, Blood.

[39]  L. Lanier,et al.  Ligands for natural killer cell receptors: redundancy or specificity , 2001, Immunological reviews.

[40]  A. Cumano,et al.  Identification of committed NK cell progenitors in adult murine bone marrow , 2001, European journal of immunology.

[41]  M. Caligiuri,et al.  Human natural killer cells: a unique innate immunoregulatory role for the CD56bright subset , 2001 .

[42]  O. Lantz,et al.  Differential requirement for the transcription factor PU.1 in the generation of natural killer cells versus B and T cells. , 2001, Blood.

[43]  M. Trevisan,et al.  Resolution of pluripotential intermediates in murine hematopoietic differentiation by global complementary DNA amplification from single cells: confirmation of assignments by expression profiling of cytokine receptor transcripts. , 2001, Blood.

[44]  Hiroshi Kawamoto,et al.  Commitment to natural killer cells requires the helix–loop–helix inhibitor Id2 , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[45]  Y. Kitamura,et al.  Inhibitory effect on natural killer activity of microphthalmia transcription factor encoded by the mutant mi allele of mice. , 2001, Blood.

[46]  K. Pfeffer,et al.  Signal Via Lymphotoxin-βR on Bone Marrow Stromal Cells Is Required for an Early Checkpoint of NK Cell Development1 , 2001, The Journal of Immunology.

[47]  M. Caligiuri,et al.  Fatal Leukemia in Interleukin 15 Transgenic Mice Follows Early Expansions in Natural Killer and Memory Phenotype Cd8+ T Cells , 2001, The Journal of experimental medicine.

[48]  A. Bakker,et al.  Id2 and Id3 Inhibit Development of Cd34+ Stem Cells into Predendritic Cell (Pre-Dc)2 but Not into Pre-Dc1 , 2000, The Journal of experimental medicine.

[49]  Scott R. Presnell,et al.  Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function , 2000, Nature.

[50]  T. Waldmann,et al.  IL-2-induced activation-induced cell death is inhibited in IL-15 transgenic mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[51]  J. Renauld,et al.  Cytokine Production and Killer Activity of NK/T-NK Cells Derived with IL-2, IL-15, or the Combination of IL-12 and IL-181 , 2000, The Journal of Immunology.

[52]  C. Roth,et al.  Clonal acquisition of inhibitory Ly49 receptors on developing NK cells is successively restricted and regulated by stromal class I MHC. , 2000, Immunity.

[53]  B. Pulendran,et al.  Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells. , 2000, Blood.

[54]  T. Hongyo,et al.  Specific c-kit mutations in sinonasal natural killer/T-cell lymphoma in China and Japan. , 2000, Cancer research.

[55]  W. Yokoyama,et al.  Nonstochastic Coexpression of Activation Receptors on Murine Natural Killer Cells , 2000, The Journal of experimental medicine.

[56]  H. Macdonald,et al.  Notch1 Deficiency Dissociates the Intrathymic Development of Dendritic Cells and T Cells , 2000, The Journal of experimental medicine.

[57]  L. Presta,et al.  Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets , 2000, Nature Medicine.

[58]  I. Weissman,et al.  A clonogenic common myeloid progenitor that gives rise to all myeloid lineages , 2000, Nature.

[59]  P. Morrissey,et al.  Reversible Defects in Natural Killer and Memory Cd8 T Cell Lineages in Interleukin 15–Deficient Mice , 2000, The Journal of experimental medicine.

[60]  J. Trapani,et al.  Differential Tumor Surveillance by Natural Killer (Nk) and Nkt Cells , 2000, The Journal of experimental medicine.

[61]  J. D. Di Santo,et al.  The receptor tyrosine kinase c-kit provides a critical signal for survival, expansion, and maturation of mouse natural killer cells. , 2000, Blood.

[62]  R. Medzhitov,et al.  Innate immune recognition: mechanisms and pathways , 2000, Immunological reviews.

[63]  T. Ikawa,et al.  Commitment of Common T/Natural Killer (Nk) Progenitors to Unipotent T and Nk Progenitors in the Murine Fetal Thymus Revealed by a Single Progenitor Assay , 1999, The Journal of experimental medicine.

[64]  S. Akira,et al.  Impairment of Natural Killer Cytotoxic Activity and Interferon γ Production in Ccaat/Enhancer Binding Protein γ–Deficient Mice , 1999, The Journal of experimental medicine.

[65]  S. Neben,et al.  Defects in Hemopoietic Stem Cell Activity in Ikaros Mutant Mice , 1999, The Journal of experimental medicine.

[66]  I. Puzanov,et al.  Differentiation of NK1.1+, Ly49+ NK cells from flt3+ multipotent marrow progenitor cells. , 1999, Journal of immunology.

[67]  A. Gaggero,et al.  IL‐15/IL‐15Rα Intracellular Trafficking in Human Cells and Protection from Apoptosisa a , 1999 .

[68]  D. Chaplin,et al.  Requirement for membrane lymphotoxin in natural killer cell development. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[69]  H. Young,et al.  IL-18 is a potent coinducer of IL-13 in NK and T cells: a new potential role for IL-18 in modulating the immune response. , 1999, Journal of immunology.

[70]  Ahmed Mansouri,et al.  Development of peripheral lymphoid organs and natural killer cells depends on the helix–loop–helix inhibitor Id2 , 1999, Nature.

[71]  E. Alnemri,et al.  Natural Killer (NK) Cell–mediated Cytotoxicity: Differential Use of  TRAIL and Fas Ligand by Immature and Mature Primary Human NK Cells , 1998, The Journal of experimental medicine.

[72]  Takeshi Matsunaga,et al.  What brought the adaptive immune system to vertebrates? ‐ The jaw hypothesis and the seahorse , 1998, Immunological reviews.

[73]  Steven F. Ziegler,et al.  Defective IL7R expression in T-B+NK + severe combined immunodeficiency , 1998, Nature Genetics.

[74]  G. Trinchieri,et al.  Differentiation of human NK cells into NK1 and NK2 subsets. , 1998, Journal of immunology.

[75]  J. Altman,et al.  Mouse CD94/NKG2A Is a Natural Killer Cell Receptor for the Nonclassical Major Histocompatibility Complex (MHC) Class I Molecule Qa-1b , 1998, The Journal of experimental medicine.

[76]  M. Caligiuri,et al.  Flt3 Ligand Promotes the Generation of a Distinct CD34+Human Natural Killer Cell Progenitor That Responds to Interleukin-15 , 1998 .

[77]  T. Dassopoulos,et al.  IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. , 1998, Immunity.

[78]  B. Blom,et al.  Early stages in the development of human T, natural killer and thymic dendritic cells , 1998, Immunological reviews.

[79]  N Muthusamy,et al.  The Ets-1 transcription factor is required for the development of natural killer cells in mice. , 1998, Immunity.

[80]  M. Caligiuri,et al.  Evaluation of natural killer cell expansion and activation in vivo with daily subcutaneous low-dose interleukin-2 plus periodic intermediate-dose pulsing , 1998, Cancer Immunology, Immunotherapy.

[81]  M. Ross,et al.  Differential expression and function of L-selectin on CD56bright and CD56dim natural killer cell subsets. , 1998, Journal of immunology.

[82]  T. Mak,et al.  The Transcription Factor Interferon Regulatory Factor 1 (IRF-1) Is Important during the Maturation of Natural Killer 1.1+ T Cell Receptor–α/β+ (NK1+ T) Cells, Natural Killer Cells, and Intestinal Intraepithelial T Cells , 1998, The Journal of experimental medicine.

[83]  J. Bell,et al.  HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C , 1998, Nature.

[84]  S. Lyman,et al.  c-kit ligand and Flt3 ligand: stem/progenitor cell factors with overlapping yet distinct activities. , 1998, Blood.

[85]  T. Waldmann,et al.  Requirement for IRF-1 in the microenvironment supporting development of natural killer cells , 1998, Nature.

[86]  J. Orange,et al.  Early Murine Cytomegalovirus (MCMV) Infection Induces Liver Natural Killer (NK) Cell Inflammation and Protection Through Macrophage Inflammatory Protein 1α (MIP-1α)–dependent Pathways , 1998, The Journal of experimental medicine.

[87]  I. Weissman,et al.  Identification of Clonogenic Common Lymphoid Progenitors in Mouse Bone Marrow , 1997, Cell.

[88]  G. Nolan,et al.  Inhibition of T Cell and Promotion of Natural Killer Cell Development by the Dominant Negative Helix Loop Helix Factor Id3 , 1997, The Journal of experimental medicine.

[89]  I. Puzanov,et al.  Generation of Lytic Natural Killer 1.1+, Ly-49− Cells from Multipotential Murine Bone Marrow Progenitors in a Stroma-free Culture: Definition of Cytokine Requirements and Developmental Intermediates , 1997, The Journal of experimental medicine.

[90]  B. Blom,et al.  Fetal liver contains committed NK progenitors, but is not a site for development of CD34+ cells into T cells. , 1997, Journal of immunology.

[91]  H. Dadi,et al.  Human immune disorder arising from mutation of the α chain of the interleukin-2 receptor , 1997 .

[92]  T. Mak,et al.  Abnormal Development of Intestinal Intraepithelial Lymphocytes and Peripheral Natural Killer Cells in Mice Lacking the IL-2 Receptor β Chain , 1997, The Journal of experimental medicine.

[93]  S. R. Viana,et al.  Phenotypic and functional evaluation of natural killer cells in thymectomized children. , 1996, Clinical immunology and immunopathology.

[94]  A. Sharpe,et al.  Selective defects in the development of the fetal and adult lymphoid system in mice with an Ikaros null mutation. , 1996, Immunity.

[95]  L. Azzoni,et al.  Definition of a natural killer NKR-P1A+/CD56-/CD16- functionally immature human NK cell subset that differentiates in vitro in the presence of interleukin 12 [published erratum appears in J Exp Med 1997 Mar 17;185(6):1150-1] , 1996, The Journal of experimental medicine.

[96]  M. Caligiuri,et al.  Role of interleukin-15 in the development of human CD56+ natural killer cells from CD34+ hematopoietic progenitor cells. , 1996, Blood.

[97]  F. Alt,et al.  Increased T-cell apoptosis and terminal B-cell differentiation induced by inactivation of the Ets-1 proto-oncogene , 1995, Nature.

[98]  R. Dubose,et al.  Identification and cloning of a novel IL‐15 binding protein that is structurally related to the alpha chain of the IL‐2 receptor. , 1995, The EMBO journal.

[99]  S. Goff,et al.  Targeted disruption of the flk2/flt3 gene leads to deficiencies in primitive hematopoietic progenitors. , 1995, Immunity.

[100]  H. Nakauchi,et al.  Lymphokine requirement for the generation of natural killer cells from CD34+ hematopoietic progenitor cells. , 1995, Blood.

[101]  A. Fischer,et al.  Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor gamma chain. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[102]  R. Spritz.  The molecular basis of human piebaldism. , 1994, Pigment cell research.

[103]  E. Scott,et al.  Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. , 1994, Science.

[104]  J. Miller,et al.  Differentiation of natural killer (NK) cells from human primitive marrow progenitors in a stroma-based long-term culture system: identification of a CD34+7+ NK progenitor. , 1994, Blood.

[105]  R. Zinkernagel,et al.  Immune responses in interleukin-2-deficient mice. , 1993, Science.

[106]  W. Leonard,et al.  Interleukin-2 receptor γ chain mutation results in X-linked severe combined immunodeficiency in humans , 1993, Cell.

[107]  E. Reinherz,et al.  A population of early fetal thymocytes expressing FcγRII III contains precursors of T lymphocytes and natural killer cells , 1992, Cell.

[108]  L. Lanier,et al.  Ontogeny of human natural killer (NK) cells: fetal NK cells mediate cytolytic function and express cytoplasmic CD3 epsilon,delta proteins , 1992, The Journal of experimental medicine.

[109]  E. Ciccone,et al.  In vitro proliferation and cloning of CD3- CD16+ cells from human thymocyte precursors , 1991, The Journal of experimental medicine.

[110]  J. Izbicki,et al.  Posttraumatic splenectomy does not influence human peripheral blood mononuclear cell subsets. , 1991, Journal of clinical & laboratory immunology.

[111]  R. E. Schwarz,et al.  Effects of splenectomy on the development of tumor-specific immunity. , 1990, The Journal of surgical research.

[112]  N. Flomenberg,et al.  Absence of interleukin 2 production in a severe combined immunodeficiency disease syndrome with T cells , 1990, The Journal of experimental medicine.

[113]  L. Lanier,et al.  The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes. , 1986, Journal of immunology.

[114]  M. Hurme,et al.  The development of NK cell activity in thymectomized bone marrow chimaeras. , 1984, Immunology.

[115]  L. Businco,et al.  Severe combined immunodeficiencies, primary T-cell defects and DiGeorge syndrome in humans: characterization by monoclonal antibodies and natural killer cell activity. , 1983, Clinical immunology and immunopathology.

[116]  J. Ben-Ezra,et al.  Natural killer cells in mice treated with 89strontium: normal target-binding cell numbers but inability to kill even after interferon administration. , 1979, Journal of immunology.

[117]  W. Seaman,et al.  Natural killer cells, bone, and the bone marrow: studies in estrogen-treated mice and in congenitally osteopetrotic (mi/mi) mice. , 1979, Journal of immunology.

[118]  R. Herberman,et al.  Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. II. Characterization of effector cells , 1975, International journal of cancer.

[119]  R. Vance,et al.  Regulation of the natural killer cell receptor repertoire. , 2001, Annual review of immunology.

[120]  M. Caligiuri,et al.  Potential mechanisms of human natural killer cell expansion in vivo during low-dose IL-2 therapy. , 2000, The Journal of clinical investigation.

[121]  T. Mak,et al.  Deficiency in the Transcription Factor Interferon Regulatory Factor (Irf)-2 Leads to Severely Compromised Development of Natural Killer and T Helper Type 1 Cells , 2000, The Journal of experimental medicine.

[122]  M. Caligiuri,et al.  Selective modulation of human natural killer cells in vivo after prolonged infusion of low dose recombinant interleukin 2. , 1993, The Journal of clinical investigation.

[123]  H. Ljunggren,et al.  In search of the 'missing self': MHC molecules and NK cell recognition. , 1990, Immunology today.

[124]  P. Vassalli,et al.  Administration of recombinant interleukin 2 to mice enhances production of hemopoietic and natural killer cells , 1986, European journal of immunology.